Kazuo Sonoki Selected Research

We 201

11/2009	Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
2/2008	Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
3/2003	Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuo Sonoki Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 05/2013 - 02/2008
4	Periodontitis 01/2009 - 09/2007
4	Atherosclerosis 01/2007 - 09/2002
3	Neoplasms (Cancer) 05/2013 - 01/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2013 - 02/2008
2	Pneumonia (Pneumonitis) 02/2010 - 01/2009
2	Diabetes Mellitus 08/2003 - 09/2002
1	Heart Diseases (Heart Disease) 01/2014
1	Stroke (Strokes) 01/2014
1	Frailty 05/2013
1	Bites and Stings (Sting) 01/2013
1	Asthma (Bronchial Asthma) 12/2011
1	Polyps 12/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2010
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2009
1	Hyperglycemia 01/2007
1	Inflammation (Inflammations) 01/2007
1	Periodontal Diseases (Periodontal Disease) 11/2006
1	Hemorrhage 11/2006
1	Necrosis 06/2006
1	Hepatitis 07/2003
1	Infections 07/2003

Drug/Important Bio-Agent (IBA)

6	oxidized low density lipoproteinIBA 11/2009 - 09/2002
4	Hormones (Hormone)IBA 01/2009 - 09/2007
3	We 201IBA 11/2009 - 03/2003
3	Dehydroepiandrosterone (DHEA)IBA 01/2009 - 09/2007
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2009 - 09/2007
2	Serum AlbuminIBA 01/2014 - 02/2010
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2009 - 02/2008
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2009 - 09/2002
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 11/2009 - 02/2008
1	Insulin (Novolin)FDA Link 01/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	HDL LipoproteinsIBA 12/2011
1	HDL CholesterolIBA 12/2011
1	Secretory Phospholipases A2IBA 09/2010
1	AlbuminsIBA 02/2010
1	Aryldialkylphosphatase (Paraoxonase)IBA 11/2009
1	HomocysteineIBA 11/2009
1	Immunoglobulin A (IgA)IBA 01/2009
1	SteroidsIBA 10/2008
1	Chromogranin AIBA 06/2008
1	ChemokinesIBA 02/2008
1	Antihypertensive Agents (Antihypertensives)IBA 02/2008
1	Lipoproteins (Lipoprotein)IBA 02/2008
1	Simvastatin (Zocor)FDA LinkGeneric 02/2008
1	low density lipoprotein inhibitorIBA 02/2008
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2007
1	C-Reactive ProteinIBA 01/2007
1	Lipid PeroxidesIBA 11/2006
1	NigericinIBA 06/2006
1	fenofibric acid FDA Link 08/2003
1	DilazepIBA 08/2003

Therapy/Procedure

1	Activities of Daily Living (ADL) 05/2013
1	Glycemic Control 01/2007
1	Therapeutics 11/2006
1	Oral Surgical Procedures 07/2003